COMP <GO>
BNTX vs BIIB // EV/EBITDA & P/E VALUATION
BioNTech SE (NASDAQ) VS. Biogen Inc. (NASDAQ) • 15-METRIC TALLY: BNTX 5
— BIIB 7
▲ EV/EBITDA & P/E VALUATION LEADER: BNTX
LAST: $88.17 (-1.08%) • MKT CAP: $22.39B
valuation
21.0x
LAST: $253.62 (+1.59%) • MKT CAP: $36.90B
valuation
22.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNTX VS. BIIB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BNTX | BIIB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 75.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 6.40% | +3.50 | BNTX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 21.0x | 22.3x | -1.30 | BNTX | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 5.56% | -3.35 | BIIB | /fcf-yield <GO> |
| Operating Margin | 13.90% | 15.90% | -2.00 | BIIB | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 13.10% | -2.20 | BIIB | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | 2.20% | +12.10 | BNTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 3.70 | +0.04 | BNTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | BNTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.4 | 61.8 | -18.40 | BIIB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.10 | -0.08 | BIIB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 26.5x | +1.10 | BIIB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.39B | $36.90B | -$14.51B | BIIB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BNTX REV | BIIB REV | BNTX GROSS % | BIIB GROSS % | BNTX FCF | BIIB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $9.89B | — | 75.7% | — | $2.05B |
| FY 2024 | — | $9.68B | — | 76.1% | — | $2.72B |
| FY 2023 | — | $9.84B | — | — | — | $1.10B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNTX // BETA 1.02
BIIB // BETA 1.10